1.Roadmapping technique in the hybrid operating room for the microsurgical treatment of complex intracranial aneurysms
Juan Luis GÓMEZ-AMADOR ; Cristopher G VALENCIA-RAMOS ; Marcos Vinicius SANGRADOR-DEITOS ; Aldo EGUILUZ-MELENDEZ ; Gerardo Y GUINTO-NISHIMURA ; Alan HERNÁNDEZ-HERNÁNDEZ ; Samuel ROMANO-FEINHOLZ ; Luis Alberto ORTEGA-PORCAYO ; Sebastián VELASCO-TORRES ; Jose J MARTÍNEZ-MANRIQUE ; Juan Jose RAMÍREZ-ANDRADE ; Marco ZENTENO-CASTELLANOS
Journal of Cerebrovascular and Endovascular Neurosurgery 2023;25(1):50-61
Objective:
To describe the roadmapping technique and our three-year experience in the management of intracranial aneurysms in the hybrid operating room.
Methods:
We analyzed all patients who underwent surgical clipping for cerebral aneurysms with the roadmapping technique from January 2017 to September 2019. We report demographic, clinical, and morphological variables, as well as clinical and radiological outcomes. We further describe three illustrative cases of the technique.
Results:
A total of 13 patients were included, 9 of which (69.2%) presented with subarachnoid hemorrhage, with a total of 23 treated aneurysms. All patients were female, with a mean age of 47.7 years (range 31-63). All cases were anterior circulation aneurysms, the most frequent location being the ophthalmic segment of the internal carotid artery (ICA) in 11 cases (48%), followed by posterior communicating in 8 (36%), and ICA bifurcation in 2 (8%). Intraoperative clip repositioning was required in 9 aneurysms (36%) as a result of the roadmapping technique in the hybrid operating room. There were no residual aneurysms in our series, nor reported mortality.
Conclusions
The roadmapping technique in the hybrid operating room offers a complementary tool for the adequate occlusion of complex intracranial aneurysms, as it provides a real time fluoroscopic-guided clipping technique, and clip repositioning is possible in a single surgical stage, whenever a residual portion of the aneurysm is identified. This technique also provides some advantages, such as immediate vasospasm identification and treatment with intra-arterial vasodilators, balloon proximal control for certain paraclinoid aneurysms, and simultaneous endovascular treatment in selected cases during a single stage.
2.Clinical practice guidelines on the diagnosis and treatment of gastroesophageal reflux disease (GERD).
Sollano José D. ; Romano Rommel P. ; Ibañez-Guzman Leticia ; Lontok Marie Antoinette DC. ; de Ocampo Sherrie Q. ; Policarpio Allan A. ; de Guzman Roberto N. ; Dalupang Carmelita D. ; Galang Augusto Jose G. ; Olympia Ernesto G. ; Chua Maria Anna L. ; Moscoso Bernadette A. ; Tan Jose A. ; Pangilinan John Arnel N. ; Vitug Arnold O. ; Naval Marichona C. ; Encarnacion Danilo A. ; Sy Peter P. ; Ong Evan G. ; Cabahug Oscar T. ; Daez Maria Lourdes O. ; Ismael Albert E. ; Bocobo Joseph C
Philippine Journal of Internal Medicine 2015;53(3):1-17
In the last two decades gastroesophageal reflux disease (GERD), initially thought to be a disease only common in the West, is described increasingly in Asia, including the Philippines. A recent local report indicated that the prevalence of erosive esophagitis (EE), a common complication of GERD, has more than doubled, i.e., 2.9% to 6.3%, between the two time periods of 1994-1997 and 2000-2003, respectively. GERD causes recurrent annoying symptoms which are common reasons for clinic visits and consultations thus, it is the objective of these guidelines to provide both primary care physicians (PCPs) and specialists a current, evidence-based, country-specific recommendations for the optimal management of GERD. These guidelines are intended to empower PCPs to make a clinic-based diagnosis of GERD, to start an empiric acid-suppressive therapy in the appropriate patient,and direct them to select which GERD patient may need to undergo investigations to ascertain further the diagnosis of GERD or to assess outcomes of therapy. We acknowledge that studies published in the future may influence the impact on our confidence on the recommendations enumerated in these guidelines thus, we commit to update this document when it is deemed appropriate.
Physicians, Primary Care ; Prevalence ; Specialization ; Gastroesophageal Reflux ; Ambulatory Care ; Esophagitis ;
3.Mechanical Thrombectomy Access for All? Challenges in Increasing Endovascular Treatment for Acute Ischemic Stroke in the United States
Sushanth Rao AROOR ; Kaiz S. ASIF ; Jennifer POTTER-VIG ; Arun SHARMA ; Bijoy K. MENON ; Violiza INOA ; Cynthia B. ZEVALLOS ; Jose G. ROMANO ; Santiago ORTEGA-GUTIERREZ ; Larry B. GOLDSTEIN ; Dileep R. YAVAGAL
Journal of Stroke 2022;24(1):41-48
Mechanical thrombectomy (MT) is the most effective treatment for selected patients with an acute ischemic stroke due to emergent large vessel occlusions (LVOs). There is an urgent need to identify and address challenges in access to MT to maximize the numbers of patients who can benefit from this treatment. Barriers in access to MT include delays in evaluation and accurate diagnosis of LVO leading to inappropriate triage, logistical delays related to availability of facilities and trained interventionalists, and financial hurdles that affect treatment reimbursement. Collection of regional data related to these barriers is critical to better understand current access gaps and a measurable access score to thrombectomy could be useful to plan local public health intervention.
4.Borderzone Infarcts and Recurrent Cerebrovascular Events in Symptomatic Intracranial Arterial Stenosis: A Systematic Review and Meta-Analysis
Saurav DAS ; Liqi SHU ; Rebecca J. MORGAN ; Asghar SHAH ; Fayez H. FAYAD ; Eric D. GOLDSTEIN ; Dalia CHAHIEN ; Benton MAGLINGER ; Satish Kumar BOKKA ; Cory OWENS ; Mehdi ABBASI ; Alexandra KVERNLAND ; James E. SIEGLER ; Brian Mac GRORY ; Thanh N. NGUYEN ; Karen FURIE ; Pooja KHATRI ; Eva MISTRY ; Shyam PRABHAKARAN ; David S. LIEBESKIND ; Jose G. ROMANO ; Adam de HAVENON ; Lina PALAIODIMOU ; Georgios TSIVGOULIS ; Shadi YAGHI
Journal of Stroke 2023;25(2):223-232
Background:
and Purpose Intracranial arterial stenosis (ICAS)-related stroke occurs due to three primary mechanisms with distinct infarct patterns: (1) borderzone infarcts (BZI) due to impaired distal perfusion, (2) territorial infarcts due to distal plaque/thrombus embolization, and (3) plaque progression occluding perforators. The objective of the systematic review is to determine whether BZI secondary to ICAS is associated with a higher risk of recurrent stroke or neurological deterioration.
Methods:
As part of this registered systematic review (CRD42021265230), a comprehensive search was performed to identify relevant papers and conference abstracts (with ≥20 patients) reporting initial infarct patterns and recurrence rates in patients with symptomatic ICAS. Subgroup analyses were performed for studies including any BZI versus isolated BZI and those excluding posterior circulation stroke. The study outcome included neurological deterioration or recurrent stroke during follow-up. For all outcome events, corresponding risk ratios (RRs) and 95% confidence intervals (95% CI) were calculated.
Results:
A literature search yielded 4,478 records with 32 selected during the title/abstract triage for full text; 11 met inclusion criteria and 8 studies were included in the analysis (n=1,219 patients; 341 with BZI). The meta-analysis demonstrated that the RR of outcome in the BZI group compared to the no BZI group was 2.10 (95% CI 1.52–2.90). Limiting the analysis to studies including any BZI, the RR was 2.10 (95% CI 1.38–3.18). For isolated BZI, RR was 2.59 (95% CI 1.24–5.41). RR was 2.96 (95% CI 1.71–5.12) for studies only including anterior circulation stroke patients.
Conclusion
This systematic review and meta-analysis suggests that the presence of BZI secondary to ICAS may be an imaging biomarker that predicts neurological deterioration and/or stroke recurrence.
5.Prevalence and Associations of Dural Arteriovenous Fistulae in Cerebral Venous Thrombosis: Analysis of ACTION-CVT
Aaron SHOSKES ; Liqi SHU ; Thanh N. NGUYEN ; Mohamad ABDALKADER ; James GILES ; Jordan AMAR ; James E. SIEGLER ; Nils HENNINGER ; Marwa ELNAZEIR ; Sami Al KASAB ; Piers KLEIN ; Mirjam R. HELDNER ; Kateryna ANTONENKO ; Marios PSYCHOGIOS ; David S. LIEBESKIND ; Thalia FIELD ; Ava LIBERMAN ; Charles ESENWA ; Alexis SIMPKINS ; Grace LI ; Jennifer FRONTERA ; Lindsey KUOHN ; Aaron ROTHSTEIN ; Ossama KHAZAAL ; Yasmin AZIZ ; Eva MISTRY ; Pooja KHATRI ; Setareh Salehi OMRAN ; Adeel S. ZUBAIR ; Richa SHARMA ; Robert M. STARKE ; Jacques J. MORCOS ; Jose G. ROMANO ; Shadi YAGHI ; Negar ASDAGHI
Journal of Stroke 2024;26(2):325-329